Role for highly regulated rep gene expression in adeno-associated virus vector production.
about
Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirusEfficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal sizeAdeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminusSize does matter: overcoming the adeno-associated virus packaging limitAdeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveAdeno-associated virus: from defective virus to effective vectorA muscle-targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery.Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus.Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders.Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectorsRescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.Kinetics of recombinant adeno-associated virus-mediated gene transfer.Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat.Transient demyelination increases the efficiency of retrograde AAV transductionImprovement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene.Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particlesVector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variantsA 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa.cis effects in adeno-associated virus type 2 replication.Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expressionA concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapyAltered stored calcium release in skeletal myotubes deficient of triadin and junctin.Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric InterfaceSHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells.Transient transfection methods for clinical adeno-associated viral vector production.Gene therapy vectors based on adeno-associated virus type 1.Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors.Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines.Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathway.
P2860
Q24523073-AD09E482-232F-4144-ADC5-872708708852Q24527221-14CC68C4-1686-40B9-B8FA-A417A9825F62Q24563214-B4C7A99B-A20A-43D1-BBD0-9E8D1CF39852Q24791052-CC520C00-D9B8-4D80-AF3D-2E05B3BE39B5Q27012320-863C4D15-8534-4A89-A4B4-9EB819B117EBQ27498163-BF8CCF5B-C431-4C7F-998E-12BCCDD21FADQ30483589-626508D9-9188-4247-B95E-7511441403CAQ33603458-D0C865F7-D712-4606-B5A3-82EA07C3445BQ33617271-E8AE8D3C-3696-4B1F-8F60-B0101AA6D87BQ33745707-68AD778B-794A-4126-9468-0D130A2CC9E9Q33783728-CBCE6420-3DBC-44A4-9157-0FC4D40ADB2EQ33784056-2DF9FD4B-C771-4431-9B87-9EF0CF0EA4C3Q33802149-CF2E4405-4B83-4A51-8C3B-9915EA6D54EEQ33949811-D0A7444A-6507-477C-BA67-B49B53500B0AQ34080900-113E4053-A2F1-4CF8-8CF2-CD55AE75578FQ34126901-4D6E779A-6D0C-4DFE-8D70-29A3311CD583Q35020638-3C0DAB4C-D6C1-4168-A55F-0D32971824ADQ35210473-523B4460-18A9-46C1-A91E-A76E1E6CFB2BQ35568505-7DB6BAFA-12F5-493B-9307-01E9BBE3AEB7Q35837765-D201ABFD-7699-426A-AA8E-54560E8069F1Q36074134-6A7CDC07-4441-4D16-B0D7-39197C45CC33Q36098985-D0AF96A4-004C-48F2-B895-AAB318226917Q36114228-A2312375-0A48-4152-A0FB-30FBA2A62946Q37012949-D365DB5A-3146-46DF-9243-CBFEC19A2B55Q37060519-AC39CFF5-9E0D-443C-8A28-45E294C5ECCCQ37093483-05B439AC-B05E-4E8D-9F3C-632EB6F238F4Q37433410-2F6C0496-E05C-4626-86F5-5038EF90B600Q37479802-0443049B-6295-4E74-ABE8-90952B2AC826Q39550492-090F2AD1-E3A7-4AAF-91EC-CE3FC72D2999Q39580779-EE4A93E1-1B16-435E-84AE-7EC8C18AAA26Q39582021-FB1735EB-D36E-44CD-A457-8780751A5CC0Q39589898-A59800A3-24A4-4333-A8E8-E2FF1F192EEFQ39593544-01670F37-F3F6-4BC7-98B6-C3887C6E6FBAQ39602167-D27E5C5D-AA98-46AF-9E23-84AA6DC04282Q39682511-B31A063F-E8B1-433F-8F91-2A3D3D9EF491Q39682659-BBC47FAC-95AE-47EF-9FA9-33719CEB82A9Q39685433-7CF3F0B2-36AF-40D9-9A8F-62B4E559C541Q39686097-631D8B64-3FF7-4DEA-AC78-813BE399A286Q39698557-3D7EC39F-ADF5-4B90-8A5C-CB6C73ABE370Q39798744-64E23AE3-96B0-4073-A84C-53758EA0D50D
P2860
Role for highly regulated rep gene expression in adeno-associated virus vector production.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Role for highly regulated rep ...... iated virus vector production.
@en
Role for highly regulated rep ...... iated virus vector production.
@nl
type
label
Role for highly regulated rep ...... iated virus vector production.
@en
Role for highly regulated rep ...... iated virus vector production.
@nl
prefLabel
Role for highly regulated rep ...... iated virus vector production.
@en
Role for highly regulated rep ...... iated virus vector production.
@nl
P2093
P2860
P1433
P1476
Role for highly regulated rep ...... iated virus vector production.
@en
P2093
P2860
P304
P407
P577
1997-07-01T00:00:00Z